Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia

One of the most promising approaches to preventing relapse is the stimulation of the body’s own immune system to kill residual cancer cells after conventional therapy has destroyed the bulk of the tumour. In acute myeloid leukaemia (AML), the high frequency with which patients achieve first remissio...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Ghazala Naz, Orchard, Kim, Guinn, Barbara-ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406328/
https://www.ncbi.nlm.nih.gov/pubmed/30678059
http://dx.doi.org/10.3390/jcm8020134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406328/
https://www.ncbi.nlm.nih.gov/pubmed/30678059
http://dx.doi.org/10.3390/jcm8020134

Ejemplares similares